uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Sanofi R&D Boss Thinks His Team is Ready to Survive Without Besties Regeneron and Alnylam September 20, 2017 Exactech Q1 Revenue Up 6% to $69.5 Million On 21% Extremities Growth April 25, 2017 Medtronic Orders Employees to Evacuate California Facilities October 9, 2017
Sanofi R&D Boss Thinks His Team is Ready to Survive Without Besties Regeneron and Alnylam September 20, 2017
